Assessment reveals organosilane-iron nanoparticles enhanced detection of Ni (II) while indicating therapeutic potential in anticancer activity.
In this present study, we report the design and synthesis of a new Schiff base–linked silane derivative (Compound 7) via an efficient click reaction, fully characterized by 1 H and 13 C NMR, mass spectrometry, and FT‐IR spectroscopy. The triazole moiety of Compound 7 exhibited exceptional selectivity for Ni (II), achieving impressively low detection limits (LOD) of 5.2 × 10 −7 M (UV–Vis) and 6.37 × 10 −8 M (fluorescence). When immobilized on iron nanoparticles via the Stöber method, the resulting hybrid nanoparticle complex (H‐NPs) demonstrated enhanced sensing performance, with LODs of 5.5 × 10 −8 M (UV–Vis) and 1.68 × 10 −8 M (fluorescence). The Stern–Volmer constants were determined to be 2.796 × 10 8 for Compound 7 and 8.15 × 10 7 for H‐NPs, highlighting the superior quenching efficiency of the hybrid system. Beyond sensing, Compound 7 displayed significant anticancer activity against the HeLa cell line, while molecular docking studies revealed strong interactions with the 3HB4 protein (binding energy −8.04 kcal/mol), indicating a stable ligand–protein complex. Overall, these findings showcase Compound 7 as a versatile chemosensor with remarkable potential for Ni (II) detection in environmental, agricultural, and biomedical applications, combining sensitive detection, nanoparticle hybridization, and therapeutic potential in a single platform.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: